[
  {
    "title": "Effectiveness and safety of sofosbuvir/velpatasvir ± ribavirin vs glecaprevir/pibrentasvir in genotype 3 hepatitis C virus infected patients",
    "url": "https://ejhp.bmj.com/content/27/e1/e41",
    "authors": "Luis Margusino-Framiñán, Purificación Cid-Silva, Sandra Rotea-Salvo, Álvaro Mena-de-Cea, Francisco Suárez-López, Pilar Vázquez-Rodríguez, Manuel Delgado-Blanco, Ana Isabel Sanclaudio-Luhia, Isabel Martín-Herranz, Ángeles Castro-Iglesias",
    "institution": "Pharmacy Service, Universitary Hospital of A Coruña, A Coruña, Spain. Division of Clinical Virology, Biomedical Research Institute of A Coruña (INIBIC), Universitary Hospital of A Coruña (CHUAC), Sergas, University of A Coruña (UDC), A Coruña, Spain. Infectious Diseases Unit. Internal Medicine Service, Universitary Hospital of A Coruña (CHUAC), A Coruña, Spain. Hepatology Unit, Digestive System Service, University Hospital of A Coruña (CHUAC), A Coruña, Spain. Information Systems Department, University Hospital of A Coruña, A Coruña, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-002060",
    "filters": {
      "actSubs": ["Sofosbuvir / Velpatasvir", "Ribavirin", "Glecaprevir / Pibrentasvir"],
      "indication": ["Hepatitis C Genotype 3", "Liver Fibrosis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cohort (Prospective Observational Study)"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Fisher’s Exact Test", "Mann-Whitney U Test", "Real-Time Polymerase Chain Reaction"],
      "studyLength": ["1 year - 2 years"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": []
    }
  },
  {
    "title": "Evaluation of the stability of vancomycin solutions at concentrations used in clinical services",
    "url": "https://ejhp.bmj.com/content/27/e1/e87",
    "authors": "Morgane Masse, Stéphanie Genay, Anthony Martin Mena, Natacha Carta, Damien Lannoy, Christine Barthélémy, Bertrand Décaudin, Pascal Odou",
    "institution": "Univ. Lille, CHU Lille, ULR 7365–GRITA–Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-002076",
    "filters": {
      "actSubs": ["Vancomycin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)", "Mann-Whitney U Test"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Long-term stability of ready-to-use norepinephrine solution at 0.2 and 0.5 mg/mL",
    "url": "https://ejhp.bmj.com/content/27/e1/e93",
    "authors": "Sixtine Gilliot, Morgane Masse, Stéphanie Genay, Damien Lannoy, Christine Barthélémy, Bertrand Décaudin, Pascal Odou",
    "institution": "EA 7365–GRITA–Groupe de Recherche sur les formes Injectables et les Technologies Associées, University of Lille, CHU Lille, F-59000 Lille, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-002146",
    "filters": {
      "actSubs": ["Norepinephrine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography Reversed-Phase (RP-HPLC)", "Cochran Test"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Cost efficacy analysis of abiraterone in newly diagnosed high risk metastatic castration sensitive prostate cancer",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A4.1",
    "authors": "A Soares, A Alcobia",
    "institution": "Hospital Garcia De Orta, Pharmacy Department, Almada, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.8",
    "filters": {
      "actSubs": ["Abiraterone"],
      "indication": ["Prostate Cancer (Metastatic Castration Sensitive)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Application of a time slot model in oncology: delivery planning and process optimisation",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A8.2",
    "authors": "C Bertino, M Di Gerardo, A Pirrone, E Dalla Fontana, G Caravella, A Spagnuolo, R Cursano",
    "institution": "Università Degli Studi Di Milano, Scienze Farmaceutiche-Scuola Di Specializzazione Farmacia Ospedaliera, Milano, Italy. Asst Melegnano Martesana, Farmacia, Vizzolo Predabissi, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.18",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": ["pharmacoeconomy"],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Envisioning sustainability in personalised medicine: Fondo AIFA 5% and the Italian example",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A7.2",
    "authors": "F Bocchio, M Tizzoni, M Calvi, A Di Benedetto",
    "institution": "Fondazione Irccs Policlinico San Matteo Pavia, Uoc Farmacia, Pavia, Italy. Universita’ Degli Studi Di Milano, Scuola Di Specializzazione in Farmacia Ospedaliera, Pavia, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.16",
    "filters": {
      "actSubs": ["Venetoclax", "Eltrombopag", "Pembrolizumab", "Ruxolitinib", "Blinatumomab", "Trabectedina", "Cenegermin"],
      "indication": ["Leukaemia (Acute Myeloid)", "Lymphoma (Mantle Cell)", "Pure Red Cell Aplasia", "Lymphoma (Hodgkin)", "Lymphoma (non-Hodgkin)", "Myeloproliferative Neoplasm (BCR/JAK2-Rearranged)", "Leukaemia (Acute Lymphoblastic)", "Graft Versus Host Disease", "Ovarian Carcinoma", "Ovarian Serous Adenocarcinoma", "Neurotrophic Keratitis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["10 - 50"],
      "criteriaMethod": [],
      "studyLength": ["1 year - 2 years"],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": ["personalized"],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Smartphone applications for patients diagnosed with genitourinary tumours: analysis of the quality using the mobile application rating scale",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A6.1",
    "authors": "MÁ Amor, R Collado-Borrell, V Escudero-Vilaplana, A Ribed-Sánchez, A Melgarejo-Ortuño, FJ García-Moreno, S García-Sánchez, Á Narrillos-Moraza, P Ruiz-Briones, A Herranz-Alonso, M Sanjurjo-Sáez",
    "institution": "Servicio De Farmacia, Hospital General Universitario Gregorio Marañón, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.13",
    "filters": {
      "actSubs": [],
      "indication": ["Genitourinary Cancers", "Prostate Cancer", "Cervical Cancer", "Testicular Cancer", "Ovarian Carcinoma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study"],
      "setting": [],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Mobile Application Rating Scale (MARS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": ["mobileVR"],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Biological drugs for the treatment of moderate and severe plaque psoriasis: a cost analysis and an application of a correlation analysis to investigate cost effectiveness",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A1.2",
    "authors": "N Sagaria, D Mengato, I Corbucci, G Felluga, G Morandell, A Tavella",
    "institution": "School of Hospital Pharmacy, Department of Pharmaceutical Sciences University of Padova, Padova, Italy. Bolzano General Hospital, Hospital Pharmacy Department, Bolzano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.2",
    "filters": {
      "actSubs": ["Adalimumab", "Infliximab", "Guselkumab"],
      "indication": ["Psoriasis (Moderate to Severe Plaque)"],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Psoriasis Area and Severity Index (PASI)", "Correlation Analysis"],
      "studyLength": ["3 months - 5 months"],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Economic comparison of therapeutic alternatives for firstline treatment of multiple myeloma",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A2.2",
    "authors": "MD Gil-Sierra, S Fenix-Caballero, MDP Briceño-Casado, M Dominguez-Cantero, EJ Alegre-Del Rey",
    "institution": "Hospital Universitario De Puerto Real, Pharmacy, Puerto Real, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.4",
    "filters": {
      "actSubs": ["Daratumumab", "Lenalidomide", "Bortezomib", "Thalidomide", "Melphalan", "Prednisone", "Dexamethasone"],
      "indication": ["Multiple Myeloma (Newly Diagnosed)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "ABC-VEN crosstab analysis: a decision making system for anticancer medicines",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A2.3",
    "authors": "M Fragiadaki, E Rinaki, M Petrongonas, L Tzimis",
    "institution": "Chania General Hospital, Pharmacy, 73300-Chania, Greece",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.5",
    "filters": {
      "actSubs": ["Daratumumab", "Trastuzumab emtansine", "Pantoprazole"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Haematology", "Oncology", "Chemotherapy"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["ABC/Pareto Analysis"],
      "studyLength": ["5 months - 1 year"],
      "country": ["Greece"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Can rivaroxaban become cost saving compared with vitamin K antagonists in the treatment of patients with non-valvular atrial fibrillation in France?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A1.1",
    "authors": "S Robert, F Vincent, S Vengadessane",
    "institution": "Chru Nancy, Pharmacy, Vandoeuvre Les Nancy, France. Hospices Civils De Lyon, Pharmacie, Lyon, France. Université Paris Descartes, Faculté De Pharmacie De Paris, Paris, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.1",
    "filters": {
      "actSubs": ["Rivaroxaban"],
      "indication": ["Nonvalvular Atrial Fibrillation"],
      "statedClass": ["Vitamin K Antagonists", "Novel Oral Anticoagulants"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Cost effectiveness analysis of patient self-administration of medication during hospitalisation in a cardiology unit",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A6.2",
    "authors": "CA Sørensen, A De Thurah, M Lisby, C Olesen, SB Sørensen, U Enemark",
    "institution": "Hospital Pharmacy Central Denmark Region, Clinical Pharmacy-Randers Regional Hospital, Randers Nø, Denmark. Randers Regional Hospital, Medical Department-Cardiology Unit, Randers Nø, Denmark. Aarhus University, Clinical Medicine, Aarhus, Denmark. Aarhus University Hospital, Rheumatology, Aarhus, Denmark. Aarhus University Hospital, Research Centre of Emergency Medicine, Aarhus, Denmark. Hospital Pharmacy Central Denmark Region, Clinical Pharmacy-Aarhus University Hospital, Aarhus, Denmark. Aarhus University, Public Health, Aarhus, Denmark",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.14",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Cardiology"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Denmark"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": ["selfMedication"],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Evaluation of bispectral index monitoring in general anaesthesia through a health technology assessment method: a possible introduction in clinical practice in an Italian hospital?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A7.1",
    "authors": "E Guido, ME Borghesi, A Saccardi",
    "institution": "University of Milan, Specialisation School in Hospital Pharmacy, Milan, Italy. Asst Carlo Poma-Mantova, Hospital Pharmacy, Mantova, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.15",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": ["preopMedication"],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "National reporting system for drug shortages: classification and trends in reported causes from 2015 to 2018",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A5.2",
    "authors": "A Benhabib, P Maison",
    "institution": "French National Agency for Medicines and Health Products Safety, Health Products Survey, Saint-Denis, France. Strasbourg Faculty of Pharmacy, Hospital Pharmacy, Strasbourg, France. Ea 7379- Paris Est Creteil University Upec and Chic Hospital, Epidemiology Department, Créteil, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.12",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Study of the use of intravenous immunoglobulins during the fourth quarter of 2018 and analysis of its off-label use",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A2.1",
    "authors": "S Izquierdo Muñoz, A Pariente Junquera, A De Frutos Soto",
    "institution": "Hospital Clínico Universitario De Valladolid, Farmacia Hospitalaria, Valladolid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.3",
    "filters": {
      "actSubs": [],
      "indication": ["Demyelinating Neuropathies", "Myasthenia Gravis", "Myopathy", "Encephalitis", "Encephalomyelitis", "Morvan Syndrome", "Paraneoplastic Syndrome", "Refractory Atopic Dermatitis", "Paraneoplastic Dermatomyositis", "Scleroderma", "Antisynthetase Syndrome"],
      "statedClass": ["Intravenous Immunoglobulins (IVIg)"],
      "typeOfMedical": [],
      "studyDesign": ["Case-Control (Retrospective) Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Effectiveness evaluation of high cost drugs for advanced non-small-cell lung cancer: real world evidence, compliance with clinical practice guidelines and economic evaluation",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A3.1",
    "authors": "A Isoardo, E Grande, MM Ferrero, C Fruttero",
    "institution": "Ao S Croce E Carle, SC Farmacia Ospedaliera, Cuneo, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.6",
    "filters": {
      "actSubs": ["Pemetrexed", "Erlotinib", "Gefitinib", "Afatinib", "Osimertinib", "Crizotinib", "Pembrolizumab", "Nivolumab"],
      "indication": ["Advanced Non-Small Cell Lung Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Kaplan-Meier Method"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": []
    }
  },
  {
    "title": "New cancer drug approvals in Portugal",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A3.2",
    "authors": "A Alcobia, A Soares",
    "institution": "Hospital Garcia De Orta, Pharmacy Department, Almada, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.7",
    "filters": {
      "actSubs": ["Midostaurin", "Olaparib", "Brentuksimab vedotin", "Vedotin", "Pomalidomide", "Durvalumab", "Venetoclax", "Ixazomib", "Alectinib", "Atezolizumab", "Cabozantinib"],
      "indication": ["Refractory Cancer", "Metastatic Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Budget impact analysis of a natalizumab extended interval dosing regimen",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A4.2",
    "authors": "E Pierobon, A Mastrogiacomo, F Capano, D Ielo",
    "institution": "AOU San Luigi Gonzaga, Pharmacy, Turin, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.9",
    "filters": {
      "actSubs": ["Natalizumab"],
      "indication": ["Progressive Multifocal Leukoencephalopathy", "Multiple Sclerosis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["501 - 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Introduction of rituximab biosimilar: an opportunity to improve health system efficiency?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A4.3",
    "authors": "C Panciroli, L Cervi, D Mazza, G Mangoni, M Dall’aglio, F Ruggiero, ML Medaglia",
    "institution": "Asst Grande Ospedale Metropolitano Niguarda, SC Farmacia, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.10",
    "filters": {
      "actSubs": ["Rituximab"],
      "indication": [],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": ["Case-Control (Retrospective) Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": ["vigilance"],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Assessment of asthma diagnosed population eligible for new monoclonal antibody therapy and related cost in the Veneto region",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A5.1",
    "authors": "L Degli Esposti, V Perrone, D Sangiorgi, AM Menti, M Andretta",
    "institution": "Clicon SRL-Health-Economics and Outcomes Research, Clicon SRL-Health-Economics and Outcomes Research, Ravenna, Italy. Uoc Hta-Azienda Zero-Regione Veneto, Uoc Hta-Azienda Zero-Regione Veneto, Padova, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.11",
    "filters": {
      "actSubs": ["Theophylline"],
      "indication": ["Asthma (Severe Refractory)"],
      "statedClass": ["Monoclonal Antibodies", "Inhaled Corticosteroids", "Long-Acting β Adrenoceptor Agonists", "Antileukotriene Agents", "Anticholinergics", "Systemic Corticosteroids"],
      "typeOfMedical": [],
      "studyDesign": ["Case-Control (Retrospective) Study"],
      "setting": [],
      "ward": [],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Impact of supply problems in a hospital pharmacy service",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A8.1",
    "authors": "B Zarate, Á Pieras López, R Menárguez Blanc, A Iglesias Carbajo, C Álvarez Asteinza, A Lozano Blazquez, Á Arias-Martinez, I Maray Mateos, MD Macía Rivas, CL Fernández Laguna",
    "institution": "Hospital Universitario Central De Asturias, Pharmacy, Oviedo, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.17",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cohort (Prospective Observational Study)"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Hospital pharmacists aged <45 years: an employment status and job satisfaction survey in Italy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A9.1",
    "authors": "SE Campbell Davies, G Bagaglini, F Brera",
    "institution": "Italian Society of Hospital Pharmacy Sifo, Young Pharmacists, Milano, Italy. Italian Society of Hospital Pharmacy Sifo, Young Pharmacists, Roma, Italy. Italian Society of Hospital Pharmacy Sifo, Young Pharmacists, San Donà Di Piave, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.19",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": ["youngPharma"],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Implementation of home delivery and telepharmacy systems in a third level hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A9.2",
    "authors": "J Cordero-Ramos, Ú Baños-Roldán, JA Fernandez-González-Caballos, C Castillo-Martin, EM Delgado-Cuesta",
    "institution": "Hospital Universitario Virgen Macarena, Hospital Pharmacy, Seville, Spain. Hospital Universitario Virgen Macarena, Primary Care Pharmacy Department, Seville, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.20",
    "filters": {
      "actSubs": [],
      "indication": ["Multiple Sclerosis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case-Control (Retrospective) Study"],
      "setting": ["Hospital"],
      "ward": ["Outpatient Clinic"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": ["telepharmacy"],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": ["delivery"]
    }
  },
  {
    "title": "Improvement in an antimicrobial stewardship programme after implementing a screening alert system",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A10.1",
    "authors": "E Tevar, MJ Castillo Méndez, A Ferrer Machín, ML Padilla Salazar, L Abella Vázquez, J Ode Febles, K Álvarez Tosco, M Hayek Peraza, MÁ Ocaña Gómez, J Merino Alonso",
    "institution": "Hospital Nuestra Señora De La Candelaria, Pharmacy Service, Santa Cruz De Tenerife, Spain. Hospital Nuestra Señora De La Candelaria, Computer Department, Santa Cruz De Tenerife, Spain. Hospital Nuestra Señora De La Candelaria, Internal Medicine, Santa Cruz De Tenerife, Spain. Hospital Nuestra Señora De La Candelaria, Microbiology Service, Santa Cruz De Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.21",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Quasi-Experimental Design"],
      "setting": ["Hospital"],
      "ward": ["Cardiology", "Vascular Surgery", "General Surgery", "Geriatrics", "Internal Medicine", "Neurology", "Traumatology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Economic impact of the introduction of lamivudine plus dolutegravir bitherapy in HIV naive patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A10.2",
    "authors": "L Cantarelli, J Gonzalez Garcia, B Del Rosario Garcia, J Ramos Rodriguez, F Gutierrez Nicolas, J Garcia Cairos, S Garcia Gil, GJ Nazco Casariego",
    "institution": "Complejo Hospitalario Universitario De Canarias, Pharmacy, Santa Cruz De Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.22",
    "filters": {
      "actSubs": ["Dolutegravir", "Abacavir", "Lamivudine", "Emtricitabine", "Tenofovir", "Raltegravir"],
      "indication": ["HIV (Treatment-Naive)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Efficiency of precision dosing with intravenous immunoglobulins in patients with haematological malignancies",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A11.1",
    "authors": "M Dominguez Cantero, FJ Salmeron-Navas, EM Barreiro-Fernandez, C Moreno-Ramos, MP Briceño-Casado",
    "institution": "Hospital Universitario Puerto Real, Servicio De Farmacia, Cadiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.23",
    "filters": {
      "actSubs": ["Intravenous Immunoglobulin (IVIg)"],
      "indication": ["Hematologic Malignancy", "Immunodeficiency", "Autoimmune Hemolytic Anemia", "Idiopathic Thrombocytopenic Purpura"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case-Control (Retrospective) Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Economic analysis of osimertinib in previously untreated EGFR mutant advanced non-small cell lung cancer",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A11.2",
    "authors": "A Ferrer Machín, LG José Arístides, JA Martín Conde, T Betancor García, M Vera Cabrera, S Hernández Rojas, I González García, K Álvarez Tosco, J Merino Alonso",
    "institution": "Hospital Pharmacist, Pharmacy Service, Santa Cruz De Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.24",
    "filters": {
      "actSubs": ["Osimertinib", "Afatinib", "Gefitinib", "Erlotinib"],
      "indication": ["Advanced Non-Small Cell Lung Cancer (EGFR-Mutated)"],
      "statedClass": ["Tyrosine Kinase Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Assessment of regorafenib, ramucirumab and cabozantinib as secondline therapy in hepatocarcinoma and alfa-fetoprotein value ≥400 ng/mL",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A12.1",
    "authors": "M Camean-Castillo, S Fenix-Caballero, FJ Salmeron-Navas, M Dominguez-Cantero, JM Borrero-Rubio",
    "institution": "Hospital Universitario Puerto Real, Pharmacy, Puerto Real, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.25",
    "filters": {
      "actSubs": ["Regorafenib", "Ramucirumab", "Cabozantinib", "Sorafenib"],
      "indication": ["Hepatocarcinoma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Meta-Analysis"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Bucher's Method", "Shakespeare Method"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Out of supply of chemotherapy injectable medicines over 9 months: patient impact",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A12.2",
    "authors": "F Charbonneau, Y Brasleret, MA Zilavec, C Naine, J Grimaux, G Svrcek",
    "institution": "Soissons Hospital Centre, Pharmacy Unit, Soissons, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.26",
    "filters": {
      "actSubs": ["Bleomycin", "Mitomycin C", "Docetaxel"],
      "indication": ["Ovarian Carcinoma", "Bladder Cancer", "Squamous Cell Carcinoma of the Rectum", "Prostate Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Impact of French experiment for incentivising etanercept biosimilar use after 10 months",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A12.3",
    "authors": "P Paubel, A Degrassat-Théas, F Bocquet",
    "institution": "Faculté De Pharmacie De Paris, Institut Droit Et Santé- Inserm Umr S 1145, Paris, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.27",
    "filters": {
      "actSubs": ["Etanercept"],
      "indication": [],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital", "Community Pharmacy"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Cost minimisation study of the biological treatment of inflammatory bowel disease: ustekinumab versus vedolizumab",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A13.1",
    "authors": "L Cantarelli, F Gutierrez Nicolas, B Del Rosario Garcia, J Ramos Rodriguez, J Garcia Cairos, JA Morales Barrios, S Garcia Gil, GA Gonzalez De La Fuente, J Gonzalez Garcia, GJ Nazco Casariego",
    "institution": "Complejo Hospitalario Universitario De Canarias, Pharmacy, Santa Cruz De Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.28",
    "filters": {
      "actSubs": ["Ustekinumab", "Vedolizumab"],
      "indication": ["Inflammatory Bowel Disease"],
      "statedClass": ["Tumor Necrosis Factor Alpha (TNF-α) Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Case-Control (Retrospective) Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": ["pharmacoeconomy"],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Economic impact of switching the administration route of tocilizumab in polyarticular juvenile idiopathic arthritis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A13.2",
    "authors": "M Rodriguez Reyes, F Bossacoma Busquets, M Sanchez Celma, J Arrojo Suarez, A Comes Escoda, C Latre Gorbe, E Iglesias Jimenez, J Anton Lopez",
    "institution": "Hospital Clinic Barcelona, Pharmacy, Barcelona, Spain. Hospital Sant Joan De Déu/Fundació Salut Empordà, Pharmacy, Esplugues De Llobregat, Spain. Hospital Sant Joan De Déu, Pharmacy, Esplugues De Llobregat, Spain. Hospital Sant Joan De Déu, Paediatrics, Esplugues De Llobregat, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.29",
    "filters": {
      "actSubs": ["Tocilizumab"],
      "indication": ["Polyarticular Juvenile Idiopathic Arthritis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Trans-interface gain share programme for biosimilar infliximab",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A14.1",
    "authors": "C Mc Gann, S Cullen, B Love, J Carr",
    "institution": "Connolly Hospital, Pharmacy Department, Blanchardstown, Ireland",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.30",
    "filters": {
      "actSubs": ["Infliximab", "Vedolizumab"],
      "indication": [],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Rheumatology", "Gastroenterology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["5 months - 1 year"],
      "country": ["Ireland"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Cost minimisation study in severe asthma treatment",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A14.2",
    "authors": "J Ramos Rodríguez, S García Gil, L Cantarelli, J González García, C Romero Delgado, J García Cairós, G Calzado Gómez, GA González De La Fuente, B Del Rosario García, GJ Nazco Casariego, F Gutiérrez Nicolás",
    "institution": "Hospital Universitario De Canarias, Pharmacy, San Cristóbal De La Laguna, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.31",
    "filters": {
      "actSubs": ["Omalizumab"],
      "indication": ["Severe Asthma (IgE-Mediated)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case-Control (Retrospective) Study"],
      "setting": ["Hospital"],
      "ward": ["Pneumology"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Application of the ABC analysis method for optimising the stock management of medical devices in common use",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A15.1",
    "authors": "M Belhouari, N Nchinech, H Attjioui, N Bouhlala, B Elouadghiri, J Lamsaouri",
    "institution": "Mohammed V Military Training Hospital, Pharmacy, Rabat, Morocco. Mohammed V University-Faculty of Medicine and Pharmacy of Rabat, Chis, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.32",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Universal Kits", "Sterile Gloves", "Infusers", "Plaster Strips", "Guedel Cannulas", "Y Fittings"],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["ABC/Pareto Analysis"],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Evaluating the methodological quality of pivotal clinical trial publications for orphan drugs authorised in 2018. Are they reliable?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A15.2",
    "authors": "R Iglesias Gómez, F Luna, J Moya Sola, M Tordera Baviera, MJ Company Albir, T Palanques Pastor, I Beltran Garcia, JL Poveda Andres",
    "institution": "Hospital Universitario Y Politécnico La Fe De Valencia, Servicio De Farmacia, Valencia, Spain. Hospital General De Agudos Carlos G. Durand, Servicio De Farmacia, Buenos Aires, Argentina",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.33",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain", "Argentina"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": ["orphan"]
    }
  },
  {
    "title": "Cost of stockout. A growing problem",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A16.1",
    "authors": "G Rodriguez Torne, MJ Sanchez Cuenca, F Burgos Sierra, C Fernandez Oropesa",
    "institution": "Hospital De Baza, Pharmacy Service, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.34",
    "filters": {
      "actSubs": ["Piperacillin / Tazobactam", "Docetaxel", "Paclitaxel", "Levothyroxine (IV)"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": []
    }
  },
  {
    "title": "Future distribution models for paid pharmaceuticals: the patient’s perspective",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A16.2",
    "authors": "C Olesen, MN Pedersen, MS Wellner",
    "institution": "Hospital Pharmacy Central Denmark Region, Clinical Pharmacy-Aarhus, Aarhus C, Denmark. Hospital Pharmacy Central Denmark Region, Department of for Paid Pharmaceuticals, Aarhus C, Denmark",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.35",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Denmark"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": ["telepharmacy"],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": ["delivery"]
    }
  },
  {
    "title": "Impact of the implementation of the falsified medicines directive at the Lisbon Portuguese Institute of Oncology (FG, EPE)",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A16.3",
    "authors": "AC Franco, A Gouveia",
    "institution": "Lisbon Portuguese Institute of Oncology Francisco Gentil Epe, Hospitalar Pharmacy, Lisbon, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.36",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": ["falsified"]
    }
  },
  {
    "title": "Four year study of drugs shortages in two public hospitals",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A17.1",
    "authors": "A Decoene, S Traore, A Pruvost, I Walbecq, P Mazaud",
    "institution": "Ch De Dunkerque, Pharmacy, Dunkerque, France. Chu De Lille, Pharmacy, Lille, France. Ch De Valenciennes, Pharmacy, Valenciennes, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.37",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case-Control (Retrospective) Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Student's T-test"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": []
    }
  },
  {
    "title": "Four years of shortages regarding the anatomic, therapeutic and chemical classification",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A17.2",
    "authors": "A Decoene, S Traore, I Walbecq, P Mazaud",
    "institution": "Ch De Dunkerque, Pharmacy, Dunkerque, France. Chu De Lille, Pharmacy, Lille, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.38",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Cephalosporins"],
      "typeOfMedical": [],
      "studyDesign": ["Case-Control (Retrospective) Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": []
    }
  },
  {
    "title": "Impact of medicine shortages on an outpatient clinic of a general hospital ",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A18.1",
    "authors": "I Puértolas Tena, M Comet Bernad, C Moncín Torres",
    "institution": "Hospital Royo Villanova, Servicio De Farmacia, Zaragoza, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.39",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case-Control (Retrospective) Study"],
      "setting": ["Hospital"],
      "ward": ["Outpatient Clinic"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": []
    }
  },
  {
    "title": "Survey of drug shortages in Hungarian hospitals",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A18.2",
    "authors": "RG Vida, S Sebők, B Nyaka, J Hornyák, L Botz",
    "institution": "University of Pécs Faculty of Pharmacy, Department of Pharmaceutics and Central Clinical Pharmacy, Pécs, Hungary. Semmelweis University, University Pharmacy Department of Pharmacy Administration, Budapest, Hungary",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.40",
    "filters": {
      "actSubs": ["Digoxin", "Sodium Ferric Gluconate", "Phytomenadione", "Immunoglobulin", "Idarubicin", "Amoxicillin / Clavulanic acid"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Hungary"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": ["selection"],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": []
    }
  },
  {
    "title": "Drug shortages and drug unavailability: analysis from an Italian hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A19.1",
    "authors": "A Zovi, C Inserra, M Piacenza, V Stefania",
    "institution": "Asst Fatebenefratelli Sacco-L Sacco Hospital, Pharmacy, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.41",
    "filters": {
      "actSubs": ["Ampicillin", "Ceftazidime", "Midazolam", "Oxacillin", "Ferrous gluconate", "Glutathione", "Piperacillin / Tazobactam", "Lysine acetylsalicylate", "Hydrocortisone", "Suxamethonium", "Cefepime", "Methylprednisolone", "Heparin", "Atracurium", "Mupirocin", "Chlorphenamine", "Alprostadil", "Etilefrine", "Diazepam", "Lorazepam", "Fructose", "Labetalol", "Danazol", "Sodium nitroprusside"],
      "indication": [],
      "statedClass": ["Antibiotics", "Non-Steroidal Anti-Inflammatory Drugs", "Benzodiazepines", "Antihypertensives", "Dietetics", "Anaesthetics", "Urological Drugs", "Antihistamines", "Adrenergic Drugs"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": []
    }
  },
  {
    "title": "How much does falsified medicines directive actually costs? Detailed cost evaluation of serialisation in a representative sample of Hungarian hospital pharmacies",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A19.2",
    "authors": "A Fittler, K Richter, P Vajda, Z Bodrogi, RG Vida, R Bella, S Kovács, A Zemplényi, L Botz",
    "institution": "University of Pécs, Department of Pharmaceutics and Central Clinical Pharmacy, Pécs, Hungary. Szent Borbála Hospital, Department of Pharmacy, Tatabánya, Hungary. University of Pécs, Department of Pharmacoeconomics, Pécs, Hungary",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.42",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Hungary"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": ["falsified"]
    }
  },
  {
    "title": "Shortages of medicines in hospital: results of a survey on the perception of health workers in the wards VSV real world",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A20.1",
    "authors": "A Zovi, UM Musazzi, F Cilurzo, P Minghetti",
    "institution": "Asst Fatebenefratelli Sacco-L Sacco Hospital, Pharmacy, Milan, Italy. University of Milan, Department of Pharmaceutical Sciences, Milano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.43",
    "filters": {
      "actSubs": ["Danazol", "Ceftazidime", "Oxacillin", "Lysine acetylsalicylate"],
      "indication": [],
      "statedClass": ["Antibiotics", "Corticosteroids", "Gastroprotectors", "Antihypertensives", "Benzodiazepines", "Psychostimulants", "Nutritional Agents", "Antihistamines", "Blood Products", "Biologicals"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": ["selection"],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": []
    }
  },
  {
    "title": "Application of hazard vulnerability analysis to evaluate the risk level of medicine shortages",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A20.2",
    "authors": "E Di Martino, D Vinci Leonardi, R Giammona, A Provenzani, P Polidori",
    "institution": "Università Degli Studi Di Palermo, Stebicef, Palermo, Italy. Università Degli Studi Di Messina, Chimica-Biologia-Farmacia-Scienze Ambientali, Messina, Italy. Irccs Ismett, Clinical Pharmacy, Palermo, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.44",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Hazard Vulnerability Analysis"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": []
    }
  },
  {
    "title": "Management of drug shortages",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A20.3",
    "authors": "MI Bernias Domínguez, M Mañes Sevilla, B Martin Cruz, B Santiago Gallego, I Escribano Valenciano, C Moriel Sánchez",
    "institution": "Hospital Universitario De Móstoles, Hospital Pharmacy, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.45",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Antimetabolites", "Corticosteroids", "Antiarrhythmics", "Antipsychotics"],
      "typeOfMedical": [],
      "studyDesign": ["Case-Control (Retrospective) Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": []
    }
  },
  {
    "title": "Economic impact of drug shortages",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A21.1",
    "authors": "C Aparicio Carreño, Y Labeaga Beramendi, B Rodriguez, B Fernández González, A Gándara Ande, FJ Barbazán Vázquez, C Martínez-Múgica Barbosa, C Durán Román",
    "institution": "Cabueñes Hospital University, Pharmacy, Gijón, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.46",
    "filters": {
      "actSubs": ["Piperacillin / Tazobactam", "Alprostadil", "Dexchlorpheniramine", "Magnesium sulphate", "Clorazepate dipotassium", "Metoclopramide", "Sodium chloride", "Doxycycline", "Isoniazid / Pyrazinamide / Rifampicin", "BCG Vaccine (Tice strain)"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case-Control (Retrospective) Study"],
      "setting": ["Hospital", "Community Pharmacy"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": []
    }
  },
  {
    "title": "Referencing a midline: how to make a choice?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A21.2",
    "authors": "P Behague, M Debailleul, L Lampe, N Garnier, V Colas, M Raoult, F Cathelineau, N Guenault, V Leclercq, C Canevet, E Floret",
    "institution": "Hôpital Saint Philibert, Service Pharmacie, Lomme, France. Hôpital Saint Philibert, Equipe Opérationnelle D’hygiène, Lomme, France. Hôpital Saint Philibert, Service D’anesthésie, Lomme, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.47",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Midlines"],
      "studyDesign": ["Cohort (Prospective Observational Study)"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": ["youngPharma"],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": []
    }
  },
  {
    "title": "Compatibility and stability assessment of a sodium glycerophosphate formulation mixed in bags for neonatal total parenteral nutrition",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A22.1",
    "authors": "A Isoardo, E Grande, MM Ferrero, M Viglione, B Rolando, R Fruttero, C Fruttero",
    "institution": "Ao S Croce E Carle, SC Farmacia Ospedaliera, Cuneo, Italy. Università Degli Studi Di Torino, Dipartimento Di Scienza E Tecnologia Del Farmaco, Torino, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.48",
    "filters": {
      "actSubs": ["Sodium glycerophosphate"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": ["incompatibilities"]
    }
  },
  {
    "title": "Microbiological stability test of 15% topical resorcinol for quality control",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A22.2",
    "authors": "J Cordero-Ramos, M Delgado-Valverde, V Merino-Bohórquez, C Castillo-Martin, FJ Falcón-Rodríguez, M Cameán-Fernández",
    "institution": "Hospital Universitario Virgen Macarena, Hospital Pharmacy, Seville, Spain. Hospital Universitario Virgen Macarena, Microbiology Department, Seville, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.49",
    "filters": {
      "actSubs": ["Resorcinol"],
      "indication": ["Hidradenitis suppurativa"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Terlipressin pH stability for continuous infusion",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A23.1",
    "authors": "A Castro Balado, J González-López, S Blanco-Dorado, EJ Bandín-Vilar, L García-Quintanilla, I Varela-Rey, M Busto Iglesias, M González-Barcia, I Zarra-Ferro",
    "institution": "Complejo Hospitalario Universitario De Santiago De Compostela, Hospital Pharmacist Service, Santiago De Compostela, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.50",
    "filters": {
      "actSubs": ["Terlipressin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Physicochemical stability of cefepime in polypropylene syringes and in elastomeric devices",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A23.2",
    "authors": "E D’huart, H Zenier, J Vigneron, A Charmillon, B Demore",
    "institution": "University Hospital of Nancy, Pharmacy Department, Vandoeuvre Lès Nancy, France. University Hospital of Nancy, Infectious and Tropical Diseases Department, Vandoeuvre Lès Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.51",
    "filters": {
      "actSubs": ["Cefepime"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Polypropylene Syringes", "Elastomeric Devices"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Physicochemical stability of cefazolin in polypropylene syringes and in elastomeric devices",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A24.1",
    "authors": "E D’huart, N Sobalak, J Vigneron, A Charmillon, B Demore",
    "institution": "University Hospital of Nancy, Pharmacy Department, Vandoeuvre Lès Nancy, France. University Hospital of Nancy, Infectious and Tropical Diseases Department, Vandoeuvre Lès Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.52",
    "filters": {
      "actSubs": ["Cefazolin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Polypropylene Syringes", "Elastomeric Devices"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Physicochemical stability of aztreonam in polypropylene syringes at high concentration for intensive care units",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A24.2",
    "authors": "YE Nisse, J Vigneron, F Blaise, E D’huart, A Charmillon, B Demoré",
    "institution": "Chru Nancy, Pharmacy, Vandoeuvre-Lès-Nancy, France. Chru Nancy, Infectious Diseases Department, Vandoeuvre-Lès-Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.53",
    "filters": {
      "actSubs": ["Aztreonam"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Polypropylene Syringes"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Levofloxacin 0.05% eye drops: a case study",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A24.3",
    "authors": "M Martín Marqués, A De Dios López, J Del Estal Jiménez, PA López Broseta, MÁ Roch Ventura, A Sanjuan Belda, S Jornet Montaña, E Esteve Pitarch, M Vuelta Arce, M Mendoza Aguilera, L Canadell Vilarrasa",
    "institution": "Hospital Universitari Joan Xxiii, Pharmacy, Tarragona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.54",
    "filters": {
      "actSubs": ["Levofloxacin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Intravenous perfusion of ceftolozane–tazobactam using elastomeric infusion pumps",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A25.1",
    "authors": "S Rotea, M García, B Feal, C Fernández, V Giménez, I Martín",
    "institution": "Hospital Pharmacy, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.55",
    "filters": {
      "actSubs": ["Ceftolozane / Tazobactam"],
      "indication": ["Pneumonia (Hospital Acquired)", "Severe Abdominal Infection", "Severe Urinary Infection"],
      "statedClass": [],
      "typeOfMedical": ["Elastomeric Infusion Pumps"],
      "studyDesign": ["Case-Control (Retrospective) Study"],
      "setting": ["Hospital"],
      "ward": ["Home Care Unit"],
      "numPatients": ["Less than 10"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": ["homeCare"],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Treatment of recurrent otomycosis with local application of a compounded formulation of voriconazole ear drops: case series",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A25.2",
    "authors": "L Carrasco Piernavieja, E Zhan Zhou, M Dominguez Bachiller, AM Martín De Rosales Cabrera, MS Marcos Salazar, M Perez Encinas",
    "institution": "Hospital Universitario Fundación Alcorcón, Hospital Pharmacy, Alcorcón, Spain. Hospital Universitario Fundación Alcorcón, Otorhinolaryngology, Alcorcón, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.56",
    "filters": {
      "actSubs": ["Voriconazole"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)", "STATA", "McNemar Test"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Evaluation of the production accuracy and error rate in the automated compounding of cytotoxic preparations by a robot",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A26.1",
    "authors": "BR Kujau, J Raffaelli, C Klaas",
    "institution": "Universitätsklinikum Münster, Zentrale Einrichtung Apotheke, Münster, Germany. Loccioni Deutschland Gmbh, Humancare, Calw, Germany",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.57",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["More than 1000"],
      "criteriaMethod": [],
      "studyLength": ["5 months - 1 year"],
      "country": ["Germany"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Closed system transfer device based on air filtration: the drug vapour challenge",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A26.2",
    "authors": "G Levin",
    "institution": "Simplivia Healthcare, Research and Development, Hod Hasharon, Israel",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.58",
    "filters": {
      "actSubs": ["Cyclophosphamide", "Florourasil (5-FU)"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Closed System Drug-Transfer Device (CSTD)", "Vial Adaptors"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Liquid Chromatography Tandem - Mass Spectrometry (LC–MS/MS)"],
      "studyLength": [],
      "country": ["Israel"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Management of non-administered chemotherapy preparation: an opportunity to minimise drug waste in oncology pharmacy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A27.1",
    "authors": "A El Assil, C Adade, R Issa, H Bechar, A Zedou, A Fassi Fihri, Y Rahali",
    "institution": "Mohamed V University-Faculty of Medecine and Pharmacy, Department of Pharmacy, Rabat, Morocco. National Institute of Oncology-Ibn Sina University Hospital, Department of Pharmacy, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.59",
    "filters": {
      "actSubs": ["Docetaxel"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cohort (Prospective Observational Study)"],
      "setting": ["Hospital"],
      "ward": ["Centralised Cytotoxic Preparation Unit"],
      "numPatients": [],
      "numPrescriptions": ["51 - 100"],
      "criteriaMethod": [],
      "studyLength": ["5 months - 1 year"],
      "country": ["Morocco"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": ["vigilance"],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": ["incompatibilities"]
    }
  },
  {
    "title": "Comparative biophysical stability study of ziv-aflibercept (Zaltrap, opened vials) stored at 4°C and room temperature for 2 weeks",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A27.2",
    "authors": "J Hermosilla Fernández, A Salmeron García, J Cabeza, N Navas",
    "institution": "Biomedical Research Institute Ibs Granada, Analytical Chemistry-Science Faculty-University of Granada, Granada, Spain. Biomedical Research Institute Ibs Granada, Clinical Pharmacy-San Cecilio University Hospital, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.60",
    "filters": {
      "actSubs": ["Ziv-Aflibercept"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Dynamic Light Scattering", "Size-Exclusion Chromatography (SEC)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Use of cabazitaxel and reduction of waste: the potential of drug day",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A28.1",
    "authors": "L Gasperoni, M Nardelli, A Caraffa, A Colicchio, M Mancini",
    "institution": "Azienda Ospedaliera Ospedali Riuniti Marche Nord, Uoc Farmacia, Pesaro, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.61",
    "filters": {
      "actSubs": ["Cabazitaxel"],
      "indication": ["Prostate Cancer (Metastatic Castration Resistant)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Short term stability of diluted solutions of the monoclonal antibody daratumumab",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A28.2",
    "authors": "G Mangoni, F Selmin, L Camuffo, L Cancanelli, M Piccoli, M Rivano, L Cervi, F Cilurzo, P Minghetti",
    "institution": "Università Degli Studi Di Milano, School of Specialisation in Hospital Pharmacy, Milano, Italy. Università Degli Studi Di Milano, Department of Pharmaceutical Sciences, Milano, Italy. Asst Grande Ospedale Metropolitano Niguarda, SC Farmacia, Milano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.62",
    "filters": {
      "actSubs": ["Daratumumab"],
      "indication": ["Multiple Myeloma"],
      "statedClass": [],
      "typeOfMedical": ["Low Density Polyethylene (LDPE) Bags"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Size Exclusion Chromatography - High Performance Liquid Chromatography (SEC-HPLC)", "Dynamic Light Scattering", "Nanoparticle Tracking Analysis (NTA)"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Stability of compounded nivolumab solution after pneumatic system transportation",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A29.1",
    "authors": "L Camuffo, F Selmin, F Vasile, M Rivano, M Piccoli, G Mangoni, L Cancanelli, M Fazio, F Cilurzo, P Minghetti",
    "institution": "University of Milan, School in Hospital Pharmacy, Milan, Italy. Humanitas Research Hospital, Pharmacy, Rozzano, Italy. University of Milan, Department of Pharmaceutical Sciences, Milan, Italy. San Raffaele Hospital, Pharmacy, Milan, Italy. University of Milan, Department of Chemistry, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.63",
    "filters": {
      "actSubs": ["Nivolumab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Dynamic Light Scattering", "Nuclear Magnetic Resonance", "Size Exclusion Chromatography - High Performance Liquid Chromatography (SEC-HPLC)"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Increasing pharmacy productivity by expanding the role of the intravenous compounding robot in a comprehensive cancer centre",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A29.2",
    "authors": "M Capilli, M Federici, T Comandone, G Maffeis, F Foglio, L Omini, F Enrico",
    "institution": "University of Turin, Drug Science and Technology-School of Specialisation in Hospital Pharmacy, Turin, Italy. Loccioni, Angeli Di Rosora, Ancona, Italy. University of Turin, Drug Science and Technology, Turin, Italy. Fpo Irccs Candiolo, Hospital Pharmacy, Candiolo, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.64",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Mitomycin C stability according to pH and temperature conditions",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A29.3",
    "authors": "G Miralles Andreu, I Truyols García, M Pomares Bernabeu, L Soriano Irigaray, L Peral Ballester, A Navarro Ruiz",
    "institution": "Hospital General Universitario De Elche, Hospital Pharmacy Department, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.65",
    "filters": {
      "actSubs": ["Mitomycin C"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "In use physicochemical and microbiological stability of diluted solutions of the monoclonal antibody nivolumab",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A30.1",
    "authors": "M Rivano, F Selmin, L Camuffo, L Cancanelli, G Mangoni, MA Piccoli, G Longobardo, F Cilurzo, P Minghetti",
    "institution": "University of Milan, School of Hospital Pharmacy, Milan, Italy. University of Milan, Department of Pharmaceutical Sciences, Milan, Italy. Irccs San Raffaele, Pharmacy, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.66",
    "filters": {
      "actSubs": ["Nivolumab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Dynamic Light Scattering", "Size Exclusion Chromatography - High Performance Liquid Chromatography (SEC-HPLC)", "Gel Electrophoresis"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": ["flatDoses"],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Physicochemical stability of 25 mg/mL pemetrexed diarginine in partially used vials and 3 and 12 mg/mL diluted in dextrose 5% in polyolefin bag",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A30.2",
    "authors": "YE Nisse, J Vigneron, N Sobalak, B Demoré",
    "institution": "Chru Nancy, Pharmacy, Vandoeuvre-Lès-Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.67",
    "filters": {
      "actSubs": ["Pemetrexed"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Storage of nivolumab pembrolizumab and daratumumab for 14 days after compounding in the hospital pharmacy: a microbiological stability study",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A31.1",
    "authors": "L Cancanelli, F Selmin, L Camuffo, G Mangoni, M Piccoli, M Rivano, F Cilurzo, P Minghetti",
    "institution": "Università Degli Studi Di Milano, Department of Pharmaceutical Sciences, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.68",
    "filters": {
      "actSubs": ["Nivolumab", "Pembrolizumab", "Daratumumab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Particulate quality of a controlled atmosphere area. Compliance with good manufacturing practices at rest and during activity, highlighting factors impacting on contamination",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A31.2",
    "authors": "M Pottier, M Naveau, A Villain, G Strobbe, I Sakji, F Feutry, G Marliot",
    "institution": "Centre Oscar Lambret, Pharmacy, Lille, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.69",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Development and validation of a discriminative method for anthracyclines used in oncology by visible spectrometer",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A32.1",
    "authors": "CA Adade, A El Orche, H Attjioui, A Cheikh, H Mefetah, M El Karbane, M Bouatia",
    "institution": "Mohamed V University-Faculty of Medicine and Pharmacy, Analytical Chemistry Laboratory, Rabat, Morocco. University of Sultan Moulay Slimane Beni-Mellal, Faculty of Science and Technology, Beni-Mellal, Morocco. Abulcasis University of Health Sciences, Faculty of Pharmacy, Rabat, Morocco. Paediatric Hospital, Pharmacy, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.70",
    "filters": {
      "actSubs": ["Daunorubicin", "Doxorubicin", "Epirubicin"],
      "indication": [],
      "statedClass": ["Anthracyclines"],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": ["Paediatric Haematology – Oncology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Partial Least Squares Discriminant Analysis (PLS-DA)", "Ultraviolet – Visible Spectrophotometry"],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "The effects of freeze–thaw cycling on the stability of the adalimumab biosimilar SB5",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A32.2",
    "authors": "H Ebbers, J Kim, J Yun, D Park, SJ Hwang, SJ Park",
    "institution": "Biogen International GmbH, Scientific Affairs, Baar, Switzerland. Samsung Bioepis Co Ltd, Qc Group, Incheon, Korea South",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.71",
    "filters": {
      "actSubs": ["Adalimumab"],
      "indication": [],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": ["Prefilled Syringes"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Size Exclusion Chromatography - High Performance Liquid Chromatography (SEC-HPLC)", "Capillary Electrophoresis - Sodium Dodecyl Sulfate (CE-SDS) (non-reducing)", "Fluorescence Resonance Energy Transfer (FRET)"],
      "studyLength": [],
      "country": ["Switzerland", "South Korea"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": ["coldChain"],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Magistral formulation for a patient with multiple food allergy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A33.1",
    "authors": "Y Jiménez López, E Pérez Cano, M Merino Almazán, R Claramunt García, MI Sierra Torres, I Caba Porras",
    "institution": "Hospital Universitario De Jaén, Pharmacy Service, Jaén, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.72",
    "filters": {
      "actSubs": ["Iron", "Zinc", "Sirolimus"],
      "indication": ["Multiple Food Allergy (MFA)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Formulation and galenic characterisation of a tacrolimus adhesive gel for treatment of ulcerative proctitis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A33.2",
    "authors": "MF Pérez Almagro, C Perelló Alomar, MM Santandreu Estelrich, M Ortiz González, M Gómez Zamora, E Rodríguez Campos, B García García, FJ Cámara Aguilera, O Delgado Sánchez",
    "institution": "Hospital Universitario Son Espases, Hospital Pharmacy, Palma De Mallorca, Spain. Hospital Universitario Son Espases, Laboratory Medicine Department, Palma De Mallorca, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.73",
    "filters": {
      "actSubs": ["Tacrolimus"],
      "indication": ["Ulcerative Proctitis"],
      "statedClass": [],
      "typeOfMedical": ["Luer-Lock Syringes", "Rectal Cannulas"],
      "studyDesign": [],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Long term stability of a ready to use topical anaesthetic gel kit",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A34.1",
    "authors": "E Dijkers, H Polonini, A Ferreira, C Zander",
    "institution": "Global Innovation Project Manager, Fagron Bv, Rotterdam, The Netherlands. Ortofarma Analytical Services, Ortofarma Analytical Services, Matias Barbosa, Brazil. Fagron Inc, Fagron Inc, Saint Paul, USA",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.74",
    "filters": {
      "actSubs": ["Lidocaine hydrochloride", "Epinephrine bitartrate", "Tetracaine hydrochloride", "Sodium metabisulfite"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Prefilled Syringes"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High-Performance Liquid Chromatography - Ultraviolet (HPLC-UV)"],
      "studyLength": [],
      "country": ["Netherlands", "Brazil", "USA"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Compounding an oral liquid formulation of diazepam alcohol free",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A34.2",
    "authors": "R Barbosa, A Capela, C Sampaio, S Fraga, T Soares, J Campos, D Ferreira, P Costa, L Bighinati",
    "institution": "Centro Hospitalar E Universitário São João- Epe, Pharmacy, Oporto, Portugal. Faculdade De Farmácia Da Universidade Do Porto, Ucibio- Requimte-Pharmaceutical Tecnology, Oporto, Portugal. Universitá Degli Studi Di Modena E Reggio Emilia, Chimica E Tecnologia Farmaceutiche, Modena, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.75",
    "filters": {
      "actSubs": ["Diazepam"],
      "indication": ["Epilepsy"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["Portugal", "Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Paediatric drug resistant epilepsy: nitrazepam 1 mg/mL solutions to avoid clinical therapeutic error",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A35.1",
    "authors": "MA Berardi, GB Ortenzi, V Moretti, E Adresciani, AMF Garzone, S Cappanera, C Polidori, A Pompilio",
    "institution": "Università Degli Studi Di Camerino ‘Scuola Di Scienze Del Farmaco E Dei Prodotti Della Salute’, Facoltà Di Farmacia, Camerino, Italy. Ospedali Riuniti Di Ancona, Sod Farmacia Pediatrica Ospedale Pediatrico G Salesi, Ancona, Italy. Ospedali Riuniti Ancona, Sod Neuropsichiatria Infantile, Ancona, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.76",
    "filters": {
      "actSubs": ["Nitrazepam", "Levetiracetam", "Clobazam", "Topiramate"],
      "indication": ["Epilepsy (Drug-Resistant)", "Lennox–Gastaut Syndrome"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["International League Against Epilepsy Criteria", "High-Performance Liquid Chromatography - Ultraviolet (HPLC-UV)", "Triple Quadrupole Mass Spectrometer (QqQ MS)"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Analytical method validation to carry out physicochemical stability studies of methadone oral solutions",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A35.2",
    "authors": "EA Álvaro Alonso, MP Lorenzo García, FJ Rupérez Pascualena, A Aguilar Ros, P Tejedor Prado, A Lázaro Cebas, I Cañamares Orbis, S Esteban Casado, A Such Díaz, I Escobar Rodríguez",
    "institution": "Hospital Universitario Infanta Leonor, Pharmacy, Madrid, Spain. Universidad Ceu San Pablo, Pharmacy, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.77",
    "filters": {
      "actSubs": ["Methadone"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High-Performance Liquid Chromatography - Ultraviolet (HPLC-UV)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Current state of the anti-infective ophthalmic compounding formulation in pharmacy services: a national survey",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A36.1",
    "authors": "A Castro Balado, L Garcia-Quintanilla, C Mondelo-García, M González-Barcia, I Zarra-Ferro, A Fernández-Ferreiro",
    "institution": "Complejo Hospitalario Universitario De Santiago De Compostela, Hospital Pharmacist Service, Santiago De Compostela, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.78",
    "filters": {
      "actSubs": ["Vancomycin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Autologous tissue adhesive in ophthalmological surgery",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A36.2",
    "authors": "S Berisa, M Medina Persinal, N Vazquez, M Chacon, J Merayo-Lloves, A Meana, L Fernandez-Vega Cueto-Felgueroso",
    "institution": "Instituto Oftalmológico Fernández Vega, Farmacia, Oviedo, Spain. Instituto Oftalmológico Fernández-Vega, Advanced Therapies and Regenerative Medicine, Oviedo, Spain. Instituto Universitario Fernández Vega, Advanced Therapies and Regenerative Medicine, Oviedo, Spain. Instituto Universitario Fernández Vega, Ophthalmology, Oviedo, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.79",
    "filters": {
      "actSubs": ["Human fibrinogen / Human thrombin"],
      "indication": [],
      "statedClass": ["Autologous Fibrin Tissue Adhesive"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Intracameral and intrastromal voriconazole administration in fusarium keratitis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A37.1",
    "authors": "S Gutiérrez Palomo, IM Moreno Escudero, A Rochina Astorga, A Quesada Asencio, L Peral Ballester, A Navarro Ruiz",
    "institution": "Hospital General Universitario De Elche, Pharmacy, Elche, Spain. Hospital General Universitario De Elche, Ophthalmology, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.80",
    "filters": {
      "actSubs": ["Voriconazole"],
      "indication": ["Fusarium Keratitis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Content uniformity of extemporaneous compounded suspensions",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A37.2",
    "authors": "E Dijkers, H Polonini, A Ferreira",
    "institution": "Global Innovation Project Manager, Fagron Bv, Rotterdam, The Netherlands. Ortofarma Analytical Services, Ortofarma Analytical Services, Matias Barbosa, Brazil",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.81",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Oral Liquid Vehicle Range"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High-Performance Liquid Chromatography - Ultraviolet (HPLC-UV)"],
      "studyLength": [],
      "country": ["Netherlands", "Brazil"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "93% oxygen self-production: experience in an Italian hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A38.1",
    "authors": "M Lecis, E Viglione, S Strobino, G Ceravolo",
    "institution": "Asl To3, Hospital Pharmacy, Rivoli, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.82",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Randomized Controlled Trial"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Case study: development of an ointment according to the Pharmaceutical Inspection Convention guideline",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A38.2",
    "authors": "L Pascual Masiá, E Rizkallal, M Machetti, C Lacasa, MI Calvo, F Martínez-Galán",
    "institution": "University of Navarra, Department of Pharmaceutical Technology and Chemistry, Pamplona, Spain. University of Navarra, Pharmacy Services-Clínica Universitaria De Navarra, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.83",
    "filters": {
      "actSubs": ["Phenylephrine hydrochloride", "Lidocaine hydrochloride", "Hydrocortisone"],
      "indication": ["Haemorrhoid"],
      "statedClass": ["Vasoconstrictors", "Local Anaesthetics", "Glucocorticoids"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Laboratory", "Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Sterility of single use vials when accessed using a closed system transfer device",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A39.1",
    "authors": "JA Schoenenberger Arnaiz, M Nevot-Blanc, A Moroba-Estor, M Gonzalez-Garcia, M Martinez-Sogues, M Gilabert-Sotoca",
    "institution": "Hospital Universitari Arnau De Vilanova, Pharmacy, Lleida, Spain. Hospital Universitari Santa Maria, Pharmacy, Lleida, Spain. Irblleida, Clinical Trials, Lleida, Spain. Hospital Universitari Arnau De Vilanova, Microbiology, Lleida, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.84",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Single Use Vials", "Closed System Drug-Transfer Device (CSTD)"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Physicochemical stability of the bevacizumab biosimilar, ABP 215, in intravenous bags after preparation and storage",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A39.2",
    "authors": "J Seckute, I Castellanos, S Bane",
    "institution": "Amgen, Process Development, Cambridge, Massachusetts, USA",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.85",
    "filters": {
      "actSubs": ["Bevacizumab"],
      "indication": [],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Size-Exclusion Chromatography (SEC)", "Capillary Electrophoresis (CE)", "Cation Exchange Chromatography", "Subvisible Particle Testing"],
      "studyLength": [],
      "country": ["USA"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Optimisation of mixing an oral powder mixture of codeine prepared in the hospital pharmacy for filling into hard capsules",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A40.1",
    "authors": "L Bouz, S Klovrzová, L Matysová",
    "institution": "Institute for Clinical and Experimental Medicine, Hospital Pharmacy, Prague, Czech Republic. Charles University-Faculty of Pharmacy, Department of Analytical Chemistry, Hradec Králové, Czech Republic",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.86",
    "filters": {
      "actSubs": ["Codeine"],
      "indication": ["Diarrhoea (Chronic)", "Irritable Bowel Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Spectrophotometry", "Relative Standard Deviation (RSD)"],
      "studyLength": [],
      "country": ["Czech Republic"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Galenic validation of a dexamethasone 0.01% mouthwash solution to prevent everolimus related stomatitis ",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A40.2",
    "authors": "J Vicente Valor, JL Herrero Revuelta, MS Pernia López, A Herranz Alonso, M Sanjurjo Sáez",
    "institution": "Gregorio Marañón University General Hospital, Pharmacy Service, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.87",
    "filters": {
      "actSubs": ["Everolimus", "Dexamethasone"],
      "indication": ["Stomatitis", "Breast Cancer (HR Positive / HER2 Negative Metastatic)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Surface contamination with cytotoxic drugs in European hospital wards",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A41.1",
    "authors": "E Korczowska, H Jankowiak-Gracz, M Crul, J Tuerk, D Arnold, K Meier",
    "institution": "University Hospital of Lord’s Transfiguration, Hospital Pharmacy, Poznan, Poland. Amsterdam University Medical Centre, Department of Clinical Pharmacology and Pharmacy, Amsterdam, The Netherlands. Institute of Energy and Environmental Technology, Iuta, Duisburg, Germany. Department of Medical Oncology, Klinik Für Tumorbiologie, Freiburg, Germany. Institute For Applied Healthcare Sciences, Ifahs, Hamburg, Germany",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.88",
    "filters": {
      "actSubs": ["Cyclophosphamide", "Florourasil (5-FU)", "Paclitaxel", "Gemcitabine"],
      "indication": [],
      "statedClass": ["Platinum Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Liquid Chromatography Tandem - Mass Spectrometry (LC–MS/MS)", "Inductively Coupled Plasma Mass Spectrometry (ICP-MS)"],
      "studyLength": [],
      "country": ["Poland", "Netherlands", "Germany"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "The significance of pharmacy preparation in paediatrics: making individual therapies for critically ill children possible",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A41.2",
    "authors": "B Verdino, K Nemec",
    "institution": "Donauspital, Hospital Pharmacy, Vienna, Austria",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.89",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Austria"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": ["personalized"],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Hazardous drugs: impact of measures for safe handling",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A42.1",
    "authors": "S Buendía-Bravo, C Gastalver-Martin, AM Iglesias-Bolaños, C Capilla-Montes, T Cruz-Cruz",
    "institution": "Hospital Universitario Del Sureste, Pharmacy, Arganda Del Rey, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.90",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cohort (Prospective Observational Study)"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "In use physicochemical stability of pembrolizumab under the dilution condition required for use in a day hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A42.2",
    "authors": "M Piccoli, F Selmin, G Mangoni, L Camuffo, L Cancanelli, M Rivano, C Jemos, F Cilurzo, E Omodeo Salè",
    "institution": "Università Degli Studi Di Milano, Pharmaceutical Sciences, Milano, Italy. Istituto Europeo Di Oncologia, Hospital Pharmacy, Milano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.91",
    "filters": {
      "actSubs": ["Pembrolizumab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Polyolefin Infusion Bags"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Dynamic Light Scattering", "Size Exclusion Chromatography - High Performance Liquid Chromatography (SEC-HPLC)", "Nanoparticle Tracking Analysis (NTA)"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": ["flatDoses"],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Impact of the preparation of a clinical solution of rituximab 1.0 mg/mL on the particulates (aggregation) measured by dynamic light scattering: sodium chloride and glucose concentration, and agitation effect",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A43.1",
    "authors": "N Natalia-Iglesias, J Hermosilla, J Exposito, A Salmerón-Garcia, J Cabeza",
    "institution": "Science Faculty-Institute for Biomedical Research-University of Granada, Analytical Chemistry, Granada, Spain. San Cecilio University Hospital/Institute for Biomedical Research, Clinical Pharmacy, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.92",
    "filters": {
      "actSubs": ["Rituximab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Dynamic Light Scattering"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Parenteral nutrition admixtures: review of the microbiological sampling plan",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A43.2",
    "authors": "C Sampaio, A Capela, R Barbosa, S Fraga, T Soares, M Ribeiro, C Teixeira",
    "institution": "Centro Hospitalar Universitário São João, Pharmacy, 4200–319 Porto, Portugal. Centro Hospitalar Universitário São João, Clinical Pathology, 4200–319 Porto, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.93",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case-Control (Retrospective) Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Study of the Trigon depot allergy test (triamcinolone and excipients: carboxymethylcellulose, polysorbate 80) developed in the pharmacy department",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A44.1",
    "authors": "P Pacheco, N Manresa-Ramón, MA Meroño-Saura, MÁ Carvajal-Sánchez, S Clavijos-Bautista, TM Rodríguez-Martínez, C Fernández-Zamora, J Ibañez-Caturla, AM Mora-González",
    "institution": "Hospital General Universitario Morales Meseguer, Pharmacy, Murcia, Spain. Hospital General Universitario Morales Meseguer, Allergology, Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.94",
    "filters": {
      "actSubs": ["Triamcinolone", "Docetaxel"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Importance of non-sterile formulation in a paediatric hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A44.2",
    "authors": "D Gavrus Ion, JM Català Foguet, M Sanchez Celma, JA Cuartero Lozano, M Villaronga Flaqué, R Farre Riba, F Bossacoma Busquets",
    "institution": "Hospital Sant Joan De Déu, Pharmacy, Esplugues De Llobregat, Spain. Hospital Sant Joan De Déu/Fundació Salut Empordà, Pharmacy, Esplugues De Llobregat, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.95",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Digestive System and Metabolism Drugs", "Blood and Haematopoietic Derivatives", "Cardiovascular Drugs", "Dermatological Drugs", "Hormonal Drugs", "Anti-Infective Drugs", "Antineoplastics and Immunomodulators", "Musculoskeletal System Drugs", "Nervous System Drugs", "Antiparasitics", "Respiratory System Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Case-Control (Retrospective) Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Imipenem–cilastatin fortified eye drops for the treatment of corneal ulcers caused by contact lenses: development and characterisation",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A45.1",
    "authors": "P Pacheco, N Manresa-Ramón, MÁ Carvajal-Sánchez, T Rodríguez-Martínez, MA Meroño-Saura, S Clavijos-Bautista, C Fernández-Zamora, J Ibañez-Caturla",
    "institution": "Hospital General Universitario Morales Meseguer, Pharmacy, Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.96",
    "filters": {
      "actSubs": ["Imipenem / Cilastatin"],
      "indication": ["Corneal Ulcer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": ["Emergency Department", "Ophthalmology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Importance of compounding in the paediatric hospital pharmacy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A45.2",
    "authors": "JM Català Foguet, D Gavrus Ion, M Sánchez Celma, M Villaronga Flaqué, R Farré Riba, F Bossacoma Busquets",
    "institution": "Hospital Sant Joan De Déu, Pharmacy, Esplugues De Llobregat, Spain. Hospital Sant Joan De Déu/Fundació Salut Empordà, Pharmacy, Esplugues De Llobregat, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.97",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Circuit to prepare and condition oral hazardous medicines",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A46.1",
    "authors": "A Benito Reyes, C Otero Villalustre, D Dorta Vera, D Fernández Vera, MÁ Perez Cruz, J Montoya Matellanes, E Dolz Bubbi, M Lobardero Pin",
    "institution": "Complejo Hospitalario Universitario Insular Materno Infantil, Pharmacy, Las Palmas De Gran Canaria, Spain. Hospital Universitario Araba Sede Txagorritxu, Pharmacy, Alava, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.98",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],  
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Hazardous medicines in a paediatric hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A46.2",
    "authors": "D Gavrus Ion, JM Català Foguet, A Diaz Cambron, MA Romo Murillo, J Vinent Genestar, R Farré Riba, F Bossacoma Busquets",
    "institution": "Hospital Sant Joan De Déu, Pharmacy Department, Esplugues Del Llobregat Barcelona, Spain. Hospital Sant Joan De Déu/Fundació Salut Empordà, Pharmacy Department, Esplugues Del Llobregat Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.99",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Impact of serialisation on reception of medicines and activity smoothing",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A47.1",
    "authors": "P Lacassagne",
    "institution": "Intern in Pharmacy, 31270, Cugnaux, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.100",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Sodium benzoate suspension in non-ketotic hyperglycinaemia: a case report",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A47.2",
    "authors": "S Inmaculada, F Valiente Borrego, M Muros, N Lucas, MA Sarabia, MA Rodriguez, J Ramos, I Alarcon",
    "institution": "Hospital De La Vega Lorenzo Guirao, Pharmacy, Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.101",
    "filters": {
      "actSubs": ["Sodium benzoate"],
      "indication": ["Nonketotic Hyperglycinemia"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": ["orphan"],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Magistral formulation of 10% sucralfate enemas in proctitis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A37.2",
    "authors": "A Gascón Villacampa, M Pio, M Marin, N Alzueta, D Perez, M Castresana",
    "institution": "Hospital Reina Sofia- Tudela, Pharmacy, Tudela, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.82",
    "filters": {
      "actSubs": ["Sucralfate"],
      "indication": ["Proctitis", "Prostate Cancer", "Rectal Neoplasia", "Endometrial Neoplasia", "Iron Deficiency Anemia", "Diarrhoea"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case-Control (Retrospective) Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["Less than 10"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Preliminary results on the use of oral rehydration solution in the form of gelato for rehydration of children with acute gastroenteritis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A38.1",
    "authors": "G Zvigule Neidere, A Barzdina, G Laizane, I Sviestina, K Gross",
    "institution": "Riga Stradins University, Paediatrics, Riga, Latvia. Riga Stradins University, Anaesthesiology and Intensive Care, Riga, Latvia. Children’s Clinical University Hospital, Infectology, Riga, Latvia. Children’s Clinical University Hospital, Pharmacy, Riga, Latvia. Riga Technical University, Faculty of Materials Science and Applied Chemistry, Riga, Latvia",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.83",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Latvia"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Weight-lowering pseudoephedrine-based prescriptions: monitoring patient feedback after update of national price list of medicines and magistral preparation",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A38.2",
    "authors": "A Pirrone, V Marangon, AA Nisic, F Panzeri, L Cavallo, AL Manfredi, G Palmieri, MG Pizzonia, M Avantaggiato",
    "institution": "Universita Degli Studi di Milano, Scienze Farmaceutiche – Scuola di Specializzazione in Farmacia Ospedaliera, Milano, Italy. ATS Brianza, Pharmacy Service, Monza, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.84",
    "filters": {
      "actSubs": ["Pseudoephedrine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Community Pharmacy"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": ["More than 1000"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "What happens when insulin aspart is diluted in dextrose?",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A38.3",
    "authors": "LH Préta, H Henry, M Masse, N Carta, M Kouach, C Foulon, JF Goossens, D Lannoy, S Genay, B Decaudin, P Odou",
    "institution": "Université de Lille, EA 7365 – Grita – Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Lille, France. Université de Lille- Chu de Lille, EA 7365 – Grita – Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Lille, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.85",
    "filters": {
      "actSubs": ["Insulin Aspart"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High-Performance Liquid Chromatography - Ultraviolet (HPLC-UV)", "High Performance Liquid Chromatography - Mass Spectrometry Detection (HPLC-MS)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Stability study of a 10% sodium benzoate oral solution",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A39.1",
    "authors": "A Castro Balado, A Bayón Fernández, I Adán Barrientos, JM Giráldez Montero, I Varela Rey, A Fernández Ferreiro, M González Barcia, I Zarra Ferro",
    "institution": "Clinical University Hospital Santiago de Compostela Sergas, Hospital Pharmacy Department, Santiago de Compostela, Spain. Faculty of Pharmacy- University of Santiago de Compostela USC, Pharmacy and Pharmaceutical Technology Department, Santiago de Compostela, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.86",
    "filters": {
      "actSubs": ["Sodium benzoate"],
      "indication": ["Urea Cycle Defects (UCD)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Spectrophotometry"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Analysis of the regimens established at the pharmacy service for total parenteral nutrition and the use of glutamine as a source of nitrogen",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A39.2",
    "authors": "O Montero Pérez, P Selvi Sabater, A Peláez Bejarano, D Yáñez Feria, E Sánchez Gómez",
    "institution": "Hospital Juan Ramón Jiménez, Pharmacy Service, Huelva, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.87",
    "filters": {
      "actSubs": ["Glutamine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case-Control (Retrospective) Study"],
      "setting": ["Hospital"],
      "ward": ["Critical Care Unit"],
      "numPatients": [],
      "numPrescriptions": ["More than 1000"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Implementation and quality control of a 5% fructose and 10% glycerol sterile solution for digestive endoscopy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A40.1",
    "authors": "M Roche, D Lannoy, C Nassar, F Bourdon, C Berneron, J Branche, P Odou",
    "institution": "CHRU Lille, Pharmacie, Lille Cedex, France. CHRU Lille, Maladies de L’Appareil Digestif, Lille Cedex, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.88",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High-Performance Liquid Chromatography - Ultraviolet (HPLC-UV)", "Kinetic Chromogenic Method", "Light Obscuration"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Physicochemical stability of norepinephrine bitartrate in polypropylene syringes at high concentrations for intensive care units",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A40.2",
    "authors": "E D’Huart, J Vigneron, B Demoré",
    "institution": "University Hospital of Nancy, Pharmacy, Vandoeuvre Lès Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.89",
    "filters": {
      "actSubs": ["Norepinephrine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Polypropylene Syringes"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)", "Spectrophotometry"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Successful treatment of hamartoma in child syndrome after 30 months with topical administration of simvastatin/cholesterol cream: a case report",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A41.1",
    "authors": "H Crametz, D Lannoy, B Catteau, V Foulon, C Nassar, M Roche, P Odou",
    "institution": "CHRU Lille, Pharmacie, Lille Cedex, France. CHRU Lille, Dermatologie, Lille Cedex, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.90",
    "filters": {
      "actSubs": ["Simvastatin / Cholesterol (TFSC)"],
      "indication": ["Epidermical Hamartoma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Stability of chlorhexidine 0.05% eye drops compounding drug",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A41.2",
    "authors": "S Berisa, L Macia, A Fernández, FJ Otero, X García",
    "institution": "Instituto Oftalmológico Fernández Vega, Pharmacy, Oviedo, Spain. Santiago de Compostela University, Pharmacy, Santiago de Compostela, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.91",
    "filters": {
      "actSubs": ["Chlorhexidine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": ["preopMedication"],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Effectiveness of 3% topical imiquimod in off-label use for oral florida papillomatosis: a case report",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A42.1",
    "authors": "L Rendón de Lope, P Ruiz Huertas, C Donoso-Rengifo, M Murillo Izquierdo, C Castillo Martin, J Cordero Ramos, MD Alvarado Fernandez, M Fernandez Gonzalez, ML Moya Martin",
    "institution": "Hospital Universitario Virgen Macarena, Pharmacy, Seville, Spain. Hospital Universitario Virgen Macarena, Oral and Maxilofacial Surgery, Seville, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.92",
    "filters": {
      "actSubs": ["Imiquimod"],
      "indication": ["Papillomatosis (Oral Florid)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Topical cidofovir compounding cream for the treatment of disseminated infection by molluscum contagiosum",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A42.2",
    "authors": "R Barbosa, M Vieira, P Carinha, C Lisboa, N Gomes, M Costa-Silva",
    "institution": "Centro Hospitalar e Universitário São João- Epe, Pharmacy, Oporto, Portugal. Centro Hospitalar e Universitário São João- Epe, Dermatology Service, Oporto, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.93",
    "filters": {
      "actSubs": ["Cidofovir"],
      "indication": ["Molluscum Contagiosum", "Erythroderma (Severe)"],
      "statedClass": [],
      "typeOfMedical": ["Luer-Lock Syringes"],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Portugal"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Feedback from a feasibility study of allergy test preparations in day hospitalisation",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A42.3",
    "authors": "A Leleux, S Tombelle, F Danicourt",
    "institution": "Dunkerque Hospital Center, Pharmacy, Dunkerque, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.94",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Antibiotics", "Analgesics", "Local Anaesthetics", "Iodinated Contrast Products", "Non-Steroidal Anti-Inflammatory Drugs"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Dermatology", "Paediatrics", "Pneumology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Stability of 1 mg/ml and 4 mg/ml hydrocortisone solium succinate solutions in 0.9% sodium chloride and 5% glucose",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A43.1",
    "authors": "K Mihovec, R Roškar, &Zcaron; Temova Rakuša, EE Gaal",
    "institution": "UKC Ljubljana, Pharmacy, Ljubljana, Slovenia. University of Ljubljana- Faculty of Pharmacy, Biopharmaceutics and Pharmacokinetics, Ljubljana, Slovenia",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.95",
    "filters": {
      "actSubs": ["Hydrocortisone"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["Slovenia"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Physicochemical stability of cefotaxime in polypropylene syringes at high concentrations for intensive care units",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A43.2",
    "authors": "E D’Huart, J Vigneron, F Blaise, A Charmillon, B Demoré",
    "institution": "University Hospital of Nancy, Pharmacy, Vandoeuvre Lès Nancy, France. University Hospital of Nancy, Infectious and Tropical Diseases Service, Vandoeuvre Lès Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.96",
    "filters": {
      "actSubs": ["Cefotaxime"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Polypropylene Syringes"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Physicochemical stability of vancomycin hydrochloride in polypropylene syringes at high concentrations for intensive care units",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A44.1",
    "authors": "E D’Huart, J Vigneron, A Charmillon, B Demoré",
    "institution": "University Hospital of Nancy, Pharmacy, Vandoeuvre Lès Nancy, France. University Hospital of Nancy, Infectious and Tropical Diseases Service, Vandoeuvre Lès Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.97",
    "filters": {
      "actSubs": ["Vancomycin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Polypropylene Syringes"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Physical compatibility of intravenous anti-infective drugs with medications commonly used in intensive care units",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A44.2",
    "authors": "E D’Huart, J Vigneron, B Demoré",
    "institution": "University Hospital of Nancy, Pharmacy, Vandoeuvre Lès Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.98",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Anti-Infective Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Cohort (Prospective Observational Study)", "Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Ultraviolet – Visible Spectrophotometry", "Turbidimetry"],
      "studyLength": ["Less than 3 months"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": ["incompatibilities"]
    }
  },
  {
    "title": "Implementation of quality control of paediatric cytotoxic drug preparations: pilot trial with etoposide",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A45.1",
    "authors": "M Alami Chentoufi, I Bennani, M Benabbes, S Bennis, L Yachi, M Bouatia",
    "institution": "Mohamed V University, Faculty of Medicine and Pharmacy, Rabat, Morocco. Mohamed V University- Faculty of Medicine and Pharmacy, IBN Sina Hospital University Centre- Paediatric Hospital, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.99",
    "filters": {
      "actSubs": ["Etoposide"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Ultraviolet – Visible Spectrophotometry"],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Risk management of cross-contamination of paediatric anti-cancer preparations using failure mode and effects criticality analysis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A45.2",
    "authors": "M Alami Chentoufi, M Benabbes, S Bennis, L Yachi, I Bennani, A Cheikh, H Meftah, M Bouatia",
    "institution": "Mohamed V University, Faculty of Medicine and Pharmacy, Rabat, Morocco. Abulcasis University, Faculty of Pharmacy, Rabat, Morocco. Paediatric Hospital, IBN Sina Hospital University Centre, Rabat, Morocco. IBN Sina Hospital University Centre- Paediatric Hospital, University Mohamed V- Faculty of Pharmacy, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.100",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Failure Mode, Effects and Criticality Analysis (FMECA)"],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Nivolumab weight-based dosing vs flat dose economic analysis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A45.3",
    "authors": "C Bianconi, G Gandini, G Zanotti, M Dall’Ara, E Sterzi, R Barbazza, P Marini",
    "institution": "Azienda Ospedaliera Universitaria Integrata Verona, Hospital Pharmacy, Verona, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.101",
    "filters": {
      "actSubs": ["Nivolumab"],
      "indication": ["Melanoma", "Renal Cell Cancer", "Non-Small Cell Lung Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": ["flatDoses"],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Impact of a centralised intravenous additive service in patients and healthcare workers risk reduction",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A46.1",
    "authors": "Á Marcos Fendián, A Sancho Artés, P Llopis Salvia, M Climente Martí",
    "institution": "Hospital Universitario Doctor Peset, Pharmacy, Valencia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.102",
    "filters": {
      "actSubs": ["Valproic acid"],
      "indication": [],
      "statedClass": ["Antibiotics", "Antiepileptics", "Analgesics", "Proton-Pump Inhibitors", "Corticosteroids"],
      "typeOfMedical": [],
      "studyDesign": ["Case-Control (Retrospective) Study"],
      "setting": ["Hospital"],
      "ward": ["Centralised IntraVenous Additive Service"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": ["personalized"],
      "nutrition": ["nutrition"],
      "highRisk": ["highRisk"],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Preliminary microbiological study of injectable chemotherapy dose-banding",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A46.2",
    "authors": "G Dozias, C Lambert, H Hugerot, B Rey-Rubio, C Loeuillet, N Mugnier, V Cogulet",
    "institution": "CHRU Brest, Pharmacy, Brest, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.103",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Turbidimetry"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": ["flatDoses"],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "A risk analysis method to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients’ safety",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A47.1",
    "authors": "B Marzal Alfaro, CG Rodríguez-González, V Escudero-Vilaplana, JL Revuelta-Herrero, S Ibáñez-Garcia, E García Martín, E González-Haba, I Iglesias-Peinado, A Herranz, M Sanjurjo-Saez",
    "institution": "Hospital General Universitario Gregorio Marañon, Pharmacy, Madrid, Spain. College of Pharmacy- Complutense University, Pharmacology Department, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.104",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Comparative Risk Assessment", "Failure Mode, Effects and Criticality Analysis (FMECA)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "The validation of control method: the gravimetric analysis in cytotoxic drug preparation",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A47.2",
    "authors": "L Nicolas, C Blanc, C Fercocq, L Baillet, R Linossier, JL Pons",
    "institution": "Centre Hospitalier Victor Dupouy, Pharmacy, Argenteuil, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.105",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Gravimetric Analysis"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Optimisation of compounding organisation after implementing a robotic system for automated preparation of oncologic drugs",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A48.1",
    "authors": "P Silimbani, M Tontini, L Moriconi, D Paolucci, M Federici, C Masini",
    "institution": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRST IRCCS, Oncology Pharmacy Unit, Meldola FC, Italy. Loccioni, Loccioni Humancare, Moie di Maiolati- Ancona AN, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.106",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "What is the best chemical decontamination solution for conventional anti-neoplastic drugs in a hospital compounding unit?",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A48.2",
    "authors": "N Simon, P Odou, B Decaudin, P Bonnabry, S Fleury-Souverain",
    "institution": "CHRU de Lille, Institut de Pharmacie, Lille Cedex, France. Hopitaux Universitaires de Geneve, Pharmacie, Geneve, Switzerland",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.107",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France", "Switzerland"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Productivity analysis of an automated compounding system for intravenous chemotherapy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A49.1",
    "authors": "AC Riestra, MJ Tames, O Olariaga, G Cajaraville",
    "institution": "Onkologikoa, Pharmacy, San Sebastián, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.108",
    "filters": {
      "actSubs": ["Paclitaxel"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case-Control (Retrospective) Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Dose-banding gemcitabine and standardisation of chemotherapy protocols production",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A49.2",
    "authors": "C Tirone, S Bertoli, M Galassi, C Della Costanza, V Ladisa",
    "institution": "Fondazione Irccs Istituto Nazionale dei Tumori, Pharmacy, Milano, Italy. Universita’ Degli Studi di Milano, School of Hospital Pharmacy, Milano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.109",
    "filters": {
      "actSubs": ["Gemcitabine", "Bevacizumab", "Carboplatinum", "Cisplatinum", "Dacarbazine", "Docetaxel", "Oxaliplatinum"],
      "indication": ["Ovarian Carcinoma", "Cervical Cancer", "Endometrial Neoplasia", "Breast Cancer", "Non-Small Cell Lung Cancer", "Mesothelioma", "Biliopancreatic Cancer", "Uterine Leiomyosarcoma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Gynaecology", "Oncology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": ["flatDoses"],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Quality of gemcitabine ready to administer preparations",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A50.1",
    "authors": "R Trittler, H Reinhardt, MJ Hug",
    "institution": "University Medical Centre, Pharmacy, Freiburg, Germany. University Medical Centre, Haematology, Freiburg, Germany. University Medical Centre, Apotheke, Freiburg, Germany",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.110",
    "filters": {
      "actSubs": ["Gemcitabine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography with Diode-Array Detection (HPLC-DAD)", "Liquid Chromatography Mass Spectrometry (LC-MS)"],
      "studyLength": [],
      "country": ["Germany"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": ["flatDoses"],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Physical, chemical and microbiological stability of sirolimus 0.4% in topical formulations",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A50.2",
    "authors": "C Cortell, MA Martinez, C Molina, AC Cercos, M Climente, V Merino",
    "institution": "Hospital Doctor Peset, Pharmacy, Valencia, Spain. Universidad de Valencia, Pharmaceutical Technology, Valencia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.111",
    "filters": {
      "actSubs": ["Sirolimus"],
      "indication": ["Facial Angiofibroma", "Tuberous Sclerosis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High-Performance Liquid Chromatography - Ultraviolet (HPLC-UV)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "The transition from the use of bupivacaine to ropivacaine in the delivery room, in order to achieve a better analgesic effect",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A51.1",
    "authors": "S Hadad, A Ataba, P Abecassis",
    "institution": "Rambam – Health Care Campus, Pharmaceutical Services – Pharmacy Director, Haifa, Israel. Rambam Medical Centre, Pharmacy Department, Haifa, Israel. Rambam Medical Centre, Anaesthesiolgy Department, Haifa, Israel",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.112",
    "filters": {
      "actSubs": ["Ropivacaine", "Bupivacaine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Israel"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": ["preopMedication"],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Low-dose morphine solution for spinal anaesthesia – ready to use to improve patient safety in drug therapy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A51.2",
    "authors": "K Lämmle, A Kirchhoff, P Hoffmann, S Amann",
    "institution": "München Klinik, Hospital Pharmacy, München, Germany. München Klinik, Klinik für Anästhesiologie- Operative Intensivmedizin und Schmerztherapie, München, Germany",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.113",
    "filters": {
      "actSubs": ["Morphine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography Reversed-Phase (RP-HPLC)"],
      "studyLength": [],
      "country": ["Germany"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": ["preopMedication"],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Labelling without strength for a pharmaceutical preparation used in a blinded dosage adjustment of clozapine",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A51.3",
    "authors": "C Giraudeau, J Jost, M Strumia, G Arnaud, P Brosset, V Ratsimbazafy",
    "institution": "Dupuytren University Hospital, Pharmacy, 87000 Limoges, France. Mother and Child Hospital, Paediatry, 87000 Limoges, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.114",
    "filters": {
      "actSubs": ["Clozapine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Imipenem-fortified eye drops for the treatment of bacterial keratitis: development and characterisation",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A52.1",
    "authors": "A Castro Balado, X García Otero, I Zarra Ferro, M González Barcia, FJ Otero Espinar, A Fernández Ferreiro",
    "institution": "Clinical University Hospital Santiago de Compostela Sergas, Hospital Pharmacy Department, Santiago de Compostela, Spain. Health Research Institute of Santiago de Compostela Idis, Clinical Pharmacology Group, Santiago Compostela, Spain. Faculty of Pharmacy- University of Santiago de Compostela USC, Pharmacology- Pharmacy and Pharmaceutical Technology Department, Santiago de Compostela, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.115",
    "filters": {
      "actSubs": ["Imipenem"],
      "indication": ["Bacterial Keratitis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Spectrophotometry"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Galenic formulations for ophtalmologists: new formulations, prescribing pathways and patient information",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A52.2",
    "authors": "S Manzini, F Gradellini, C Polidori, G Borciani, L Fares",
    "institution": "Azienda Unità Sanitaria Locale – Irccs di Reggio Emilia, Hospital Pharmacy, Reggio Emilia, Italy. University of Camerino, Pharmacology, Camerino, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.116",
    "filters": {
      "actSubs": ["Amphotericin", "Cyclosporine", "Chlorhexidine", "Fluconazole", "Mitomycin C", "Tacrolimus", "Tobramycin", "Vancomycin", "Voriconazole"],
      "indication": [],
      "statedClass": ["Antibiotics", "Antimycotics", "Immune-Suppressors", "Immune-Modulators", "Oncologic Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["xxx"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Comparison of metabolite levels in serum and tears: implications for the dilution of autologous-serum-eye-drops",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A53.1",
    "authors": "D Wandel, C Steuer, JP Sigle, L Bernasconi, R Egger",
    "institution": "Kantonsspital Aarau, Pharmacy, Aarau, Switzerland. Kantonsspital Aarau, Clinical Chemistry and Clinical Immunology, Aarau, Switzerland. Stiftung Blutspende, SRK Aargau-Solothurn, Aarau, Switzerland",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.117",
    "filters": {
      "actSubs": [],
      "indication": ["Dry Eye Syndrome"],
      "statedClass": ["Autologous Serum Eye Drops"],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Liquid Chromatography Tandem - Mass Spectrometry (LC–MS/MS)"],
      "studyLength": [],
      "country": ["Switzerland"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Development of virtual drug information centre for pharmacy compounding area",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A53.2",
    "authors": "JA Montero Delgado, A Ferrer Machín, M Vera Cabrera, MC Jordán de Luna, L Díaz Díaz, I González García, MA Navarro Dávila, R Mesa Exposito, E Tevar Alfonso, MÁ Ocaña Gomez, FJ Merino Alonso",
    "institution": "Hospital Universitario Nuestra Señora de Candelaria, Hospital Pharmacy Department, Santa Cruz de Tenerife, Spain. Instituto Catalán de Oncología, Pharmacy Department, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.118",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": ["Printing3D"],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Stability study of (99MTC)dotatoc and (68GA)dotatoc in syringes",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A54.2",
    "authors": "S Chaïb, F Hallouard, C Darcissac, P Chennell, V Sautou, M Fraysse",
    "institution": "Groupe Hospitalier Sud-Hospices Civils de Lyon, Unité de Radiopharmacie- Service de Pharmacie, Pierre-Bénite, France. Université de Clermont Auvergne – CHU Clermont-Ferrand, CNRS- Sigma Clermont- ICCF, Clermont-Ferrand, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.120",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Nuclear Medicine"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": ["radiopharmaceuticals"],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Health hazards of raw materials used in the compounding of pharmaceuticals formulations",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A55.1",
    "authors": "EA Álvaro Alonso, P Tejedor Prado, E Izquierdo Garcia, A Such Diaz, A Lazaro Cebas, S Esteban Casado, I Cañamares Orbis, C Esteban Alba, A Santiago Perez, I Escobar Rodriguez",
    "institution": "Hospital Universitario Infanta Leonor, Pharmacy, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.121",
    "filters": {
      "actSubs": ["Atenolol", "Budesonide", "Diltiazem", "Spironolactone", "Phenobarbital", "Furosemide", "Phenol", "Boric Acid", "Dexamethasone", "Disodium tetraborate", "Triamcinolone", "Clobetasol", "Captoril"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Automation of parenteral nutrition compounding: results of gravimetric quality control before and after its implementation",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A55.2",
    "authors": "R Barbosa, S Nogueira, T Soares, S Fraga, A Silva, P Carinha",
    "institution": "Centro Hospitalar e Universitário São João- EPE, Pharmacy, Oporto, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.122",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Gravimetric Analysis"],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "A science- and risk-based strategy to qualify sterilised prefilled syringes as primary packaging material in a hospital pharmacy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A56.1",
    "authors": "K Beld, A Kuiper, S Van Berkel, H Robben, R Wijnsma, K Taxis, E Frijlink",
    "institution": "ISALA Hospital, Clinical Pharmacy, Zwolle, The Netherlands. University of Groningen, Unit of Pharmacotherapy- -Epidemiology and Pharmacoeconomics PTE2- Groningen Research Institute of Pharmacy, Groningen, The Netherlands. University of Groningen, Department of Pharmaceutical Technology and Biopharmacy, Groningen, The Netherlands",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.123",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Prefilled Syringes", "Cyclic Olefin Polymer (COP) Syringe"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Netherlands"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "New formulation of norepinephrine solution in prefilled cyclic olefin sterilised syringes",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A56.2",
    "authors": "K Beld, S Van Berkel, R Wijnsma, K Taxis, E Frijlink",
    "institution": "ISALA Hospital, Clinical Pharmacy, Zwolle, The Netherlands. University of Groningen, Unit of Pharmacotherapy- -Epidemiology and Pharmacoeconomics Pte2- Groningen Research Institute Of Pharmac, Groningen, The Netherlands. University of Groningen, Department of Pharmaceutical Technology and Biopharmacy, Groningen, The Netherlands",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.124",
    "filters": {
      "actSubs": ["Norepinephrine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Prefilled Syringes", "Cyclic Olefin Polymer (COP) Syringe"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography with Diode-Array Detection (HPLC-DAD)"],
      "studyLength": [],
      "country": ["Netherlands"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": ["incompatibilities"]
    }
  },
  {
    "title": "Paraffin oil-based emulsion: influence of gum arabic and the mixing rate on emulsion stability",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A56.3",
    "authors": "M Benabbes, M Alami Chentoufi, L Abdelkader",
    "institution": "Faculty of Medicine and Pharmacy- Mohammed V University of Rabat, Team of Formulation and Quality Control of Health Products- Faculty of Medicine and Pharmacy, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.125",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["The Hydrophilic-Lipophilic Balance (HLB)"],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Formulation and stability study of extemporaneous oral liquid dosage forms containing flecainide acetate 2 mg/ml for paediatric use",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A57.1",
    "authors": "A Casiraghi, S Loiacono, S Bordignon, R Puzziferri, F Cilurzo, P Minghetti",
    "institution": "University of Milan, Department of Pharmaceutical Sciences- Specialisation School in Pharmacy, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.126",
    "filters": {
      "actSubs": ["Flecainide acetate"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Study of stability of two liquid formulations of omeprazole elaborated in the pharmaceutical service",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A57.2",
    "authors": "E Conesa Nicolás, AM Chica Marchal, AC Viney, S Nuñez Bracamonte, C Juez Santamaría, A Lloret Llorca, B Fernández-Lobato, CN García Matillas, M Martinez Penella",
    "institution": "Hospital General Universitario Santa Lucía, Servicio de Farmacia, Cartagena- Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.127",
    "filters": {
      "actSubs": ["Omeprazole"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  },
  {
    "title": "Evaluation of the effectiveness and satisfaction of the master suspension formula for mucositis elaborated in a tertiary hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A58.1",
    "authors": "E Conesa Nicolás, AM Chica Marchal, AC Viney, S Nuñez Bracamonte, A Lloret Llorca, C Juez Santamaría, CN García Matillas, MS Garcia Simón, MDM Sanchez Catalicio",
    "institution": "Hospital General Universitario Santa Lucía, Servicio de Farmacia, Cartagena- Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.128",
    "filters": {
      "actSubs": ["Nystatin", "Methylprednisolone", "Mepivacaine", "Gentamicin"],
      "indication": ["Mucositis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": []
    }
  }
]